Protea Gets $1.7M Financing from West Virginia VC Fund | GenomeWeb

NEW YORK (GenomeWeb News) – Protea Biosciences will use a new $1.7 million investment from the state of West Virginia to continue developing a new protein biomarker technology, which will be used to identify proteins in tissue and in other biological samples.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

DuPont teams with genome editing firm Caribou Biosciences for agricultural applications of the technology.

A blogger reviews her experience learning about her gut microbiome by shipping a sample to uBiome.

In Science this week: ancient Ethiopian genome indicates greater Eurasian backflow into Africa, sequencing to diagnose cutaneous T cell lymphoma, and more.

The US House of Representatives science committee has passed a bill to require NSF to ensure it only funds projects that are in the national interest.